Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) where chiral pyrrolidine scaffolds are required. Its functional groups allow for selective coupling reactions, making it valuable in constructing complex molecules for drug discovery. Commonly employed in the preparation of protease inhibitors and other bioactive agents due to its structural compatibility with enzyme binding sites. Also utilized in research settings for the design of novel therapeutic candidates targeting neurological and metabolic disorders.